Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance).
- Citation:
- J Clin Oncol vol 37 (22) 1876-85
- Year:
- 2019
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 8
- Parents:
- 2671
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- GI
- Pharmas:
- Eli Lilly and Company, Genentech, Pfizer Inc, and Sanofi.
- Grants:
- U10CA180821 and U10CA180882 (to the Alliance for Clinical Trials in Oncology), U10CA180790 (Mayo Clinic), U10CA180791 (Memorial Sloan-Kettering), U10CA180795 (Indiana University), U10CA180799 (University of Wisconsin), U10CA180830 (USC Norris Cancer Hospital), U10CA180836 (University of Chicago), U10CA180838 (University of North Carolina), U10CA180850 (The Ohio State University), U10CA180867 (Dana-Farber Cancer Institute), and U10CA180888 (Southwest Oncology Group).
- Corr. Author:
- Authors:
- Heinz-Josef Lenz Fang-Shu Ou Alan P Venook Howard S Hochster Donna Niedzwiecki Richard M Goldberg Robert J Mayer Monica M Bertagnolli Charles D Blanke Tyler Zemla Xueping Qu Pratyaksha Wirapati Sabine Tejpar Federico Innocenti Omar Kabbarah
- Networks:
- CA011, CA136, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-OH007, OR013
- Study
- Alliance-A151425
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-80405
- Phases:
- N/A, 3
- Keywords: